DS Stage II Multiple Myeloma
3 clinical trials · Condition
◉ Watch DS Stage II Multiple Myeloma
| Record | Firm | Date |
|---|---|---|
| Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma (NCT00644228) | National Cancer Institute (NCI) | 2008-07-28 |
| Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant (NCT00114101) | National Cancer Institute (NCI) | 2004-12-15 |
| Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma (NCT00098475) | National Cancer Institute (NCI) | 2004-11-03 |
Track DS Stage II Multiple Myeloma automatically
Every clearance here is in the API, with alerts when new ones post.